Adam J Olszewski, MD¹ and Jorge J Castillo, MD²

¹Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI
²Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Alessia Bari^1*, Luigi Marcheselli^2*, Tamar Tadmor^3*, Raffaella Marcheselli^2*, Maria Christina Cox, MD PhD⁴, Samantha Pozzi^5*, Angela Ferrari^6*, Luca Baldini^7*, Paolo Gobbi^8*, Massimo Federico⁹, Aaron Polliack¹⁰ and Stefano Sacchi⁵

¹Program of Innovative Therapy in Oncology and Hematology, Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
²Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia, Modena, Italy
³Hematology-Oncology Unit, Bnai Zion Medical Center, Haifa, Israel; Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁴Hematology, Azienda Ospedaliera S. Andrea, Rome, Italy
⁵Program of Innovative Therapies in Oncology and Haematology, Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
⁶Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
⁷Division of Hematology, Fondazione IRCCS Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy
⁸Department of Internal Medicine, University of Pavia, IRCCS San Matteo Hospital Foundation, Pavia, Italy
⁹Department of Diagnostic and Clinical Medicine, and Public Health, University of Modena and Reggio Emilia, Modena, Italy
¹⁰Department of Hematology, Hadassah University Hospital, Jerusalem, Israel

Jeffery Ames, MD^1*, Manjula Maganti, MSc^2*, Bethany E Monteith, MD³, David C. Hodgson, MD^4*, Vishal Kukreti, MD⁵, John G. Kuruvilla, MD⁶, Anca Prica, MD^7*, Richard Tsang, MD^8*, Alex Sun, MD^8*, Mary Gospodarowicz, MD^9*, Melania Pintilie, MSc^10* and Michael Crump, MD¹¹

¹Kingston General Hospital, Queen's University, Kingston, ON, Canada
²Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Department of Medicine, Queen's University, Kingston, ON, Canada
⁴Radiation Medicine Programme, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Division of Medical Oncology and Hematology, University of Toronto,Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁸Radiation Medicine Programme, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
⁹Radiation Medicine Programme, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁰Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
¹¹Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Pei-Chuan Li, Ph.D.^1*, Imran N Siddiqi, M.D, Ph.D.^2*, Eric Y. Loo, M.D.^3*, Yinfei Kong, M.S.^4*, Wendy Cozen, DO, MPH⁵, Chieh-Hsi Wu, Ph.D.^6* and Jean Chen Shih, Ph.D.^1*

¹School of Pharmacy, University of Southern California, Los Angeles, CA
²Hematopathology Section, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA
³University of New Mexico School of Medicine, Albequerque, NM
⁴Keck School of Medicine of USC, University of Southern California, Los Angeles, CA
⁵Preventive Medicine and Pathology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
⁶Taipei Medical University, Taipei, Taiwan

Chan Yoon Cheah, MBBS DMedSc^1,2,3, Paul J Broeckelmann, MD^4*, Alison J Moskowitz, MD⁵, Andreas Engert, MD⁶, Mats Jerkeman, MD, PhD⁷, Tarec Christoffer El-Galaly^8*, Julie Vose⁹, Diego Villa, MD, MPH¹⁰, Joseph M. Connors, MD¹¹, Tatyana Feldman, MD¹², Dai Chihara, MD, PhD¹³, Chelsea C Pinnix, MD PhD^14*, Sarah A Milgrom, MD^14*, Bouthaina S. Dabaja, MD¹⁴, Yasuhiro Oki, MD¹⁵ and Michelle A. Fanale, MD¹³

¹Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
²School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia
³Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston
⁴Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
⁷Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
⁸Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
⁹University of Nebraska Medical Center, Omaha, NE
¹⁰BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada
¹¹British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
¹²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Dada Reyad, Associate Professor^1,2*, Fawwaz Khalid Yassin³ and Mohamed Bayoumy, MD^4*

¹Medical Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
²College of Medicine, Al-Faisal University, Riyadh, Saudi Arabia
³King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
⁴Department of Oncology, King Faisal Specialist Hospital & Research Center - Jeddah, Jeddah, Saudi Arabia

Rafael Dezen Gaiolla, MD^1*, Marcelo Padovani de Toledo Moraes, MD, PhD^2* and Deilson Elgui de Oliveira, PhD^2*

¹Botucatu Medical School, Sao Paulo State University, Botucatu, Brazil
²Botucatu Medical School, São Paulo State University, Botucatu, Brazil